Home › Funds › 683 Capital Management, LLC › SRPT

683 Capital Management, LLC position in SRPT

SAREPTA THERAPEUTICS INC · Health Care

683 Capital Management, LLC reported holding 782,500 shares of SRPT (SAREPTA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$14.1M, representing 0.75% of its reported portfolio and ranking #30 among its reported holdings. 683 Capital Management, LLC has disclosed SRPT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)782.50K sh
Reported value held$14.06M
Portfolio Weight0.75%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How 683 Capital Management, LLC's SRPT position evolved

683 Capital Management, LLC first disclosed a stake in SRPT in Q3 2023 at 20,000 shares (US$2.4M). The position peaked in Q3 2025 at 990,000 shares, worth US$19.1M. Across 12 filings, 683 Capital Management, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 782,500 shares valued at US$14.1M — an increase of 32,500 shares quarter over quarter.. Notable position changes include a 333% increase in Q4 2023 (shares rose 34% over the following quarter), a 62% increase in Q1 2025 (shares fell 73% over the following quarter), a 309% increase in Q2 2025 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 20.00K $2.42M New
Q4 2023 86.60K $8.35M Add
Q1 2024 62.83K $8.13M Reduce
Q2 2024 63.50K $10.03M Add
Q3 2024 87.22K $10.89M Add
Q4 2024 102.00K $12.40M Add
Q1 2025 165.00K $10.53M Add
Q2 2025 675.00K $11.54M Add
Q3 2025 990.00K $19.08M Add
Q4 2025 810.00K $17.43M Reduce
Q1 2026 750.00K $16.32M Reduce
Q2 2026 782.50K $14.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SRPT and 13F data

SRPT (SAREPTA THERAPEUTICS INC) is a Health Care company. 12 other funds we track also report a position in SRPT — the largest reported positions include HIGHBRIDGE CAPITAL MANAGEMENT LLC (US$49.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SRPT

All SRPT fund holders →

FAQ

How long has 683 Capital Management, LLC held SRPT?

683 Capital Management, LLC has disclosed SRPT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is 683 Capital Management, LLC's current position in SRPT?

As of Q2 2026, 683 Capital Management, LLC holds 782.50K shares of SRPT (SAREPTA THERAPEUTICS INC), valued at $14.06M, representing 0.75% of its reported portfolio and ranking #30.

Has 683 Capital Management, LLC been buying or selling SRPT?

In the latest 13F filing (Q2 2026), 683 Capital Management, LLC increased its position in SRPT. The position peaked in Q3 2025 at 990.00K shares.

Which other funds hold SRPT?

Other major institutional holders of SRPT include HIGHBRIDGE CAPITAL MANAGEMENT LLC, among 12 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.